Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Neuhaus

Showing results (281-290 of 440) with videos related to

Pageof 44
Sort By:
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|May 15, 2003
Recovery of preservation-injured primary human hepatocytes and nonparenchymal cells to tissuelike structures in large-scale bioreactors for liver support: an initial transmission electron microscopy studyJörg C Gerlach, Katrin Zeilinger, Alexander Grebe, et al.
World Journal of Gastroenterology|April 26, 2005
Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cellsDietmar Jacob, Guido Schumacher, Marcus Bahra, et al.
Surgery Today|January 2, 2016
Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolizationMaciej Malinowski, Johan Friso Lock, Daniel Seehofer, et al.
Annals of Surgery|July 2, 2003
IL-10 increases tissue injury after selective intestinal ischemia/reperfusionNatascha C Nüssler, Andrea R Müller, Hans Weidenbach, et al.
Clinical Transplantation|July 11, 2006
Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantationJan M Langrehr, Jochen Klupp, Matthias Glanemann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 22, 2006
Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trialChristoph Heidenhain, Michael Heise, Sven Jonas, et al.
Head & Neck|December 19, 2014
Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantationAnnekatrin Coordes, Andreas E Albers, Minoo Lenarz, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2013
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspectiveMassimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2008
Graft versus host disease after liver transplantation - a single center experience and review of literatureSven Kohler, Andreas Pascher, Guido Junge, et al.
Kidney International|May 30, 2008
Ischemic preconditioning produces systemic protective and adoptively transferable effectsAnja Reutzel-Selke, Johann Pratschke, Paulo N Martins, et al.
Pageof 44

Showing results (281-290 of 440) with videos related to

Sort By:
Pageof 44
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|May 15, 2003
Recovery of preservation-injured primary human hepatocytes and nonparenchymal cells to tissuelike structures in large-scale bioreactors for liver support: an initial transmission electron microscopy studyJörg C Gerlach, Katrin Zeilinger, Alexander Grebe, et al.
World Journal of Gastroenterology|April 26, 2005
Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cellsDietmar Jacob, Guido Schumacher, Marcus Bahra, et al.
Surgery Today|January 2, 2016
Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolizationMaciej Malinowski, Johan Friso Lock, Daniel Seehofer, et al.
Annals of Surgery|July 2, 2003
IL-10 increases tissue injury after selective intestinal ischemia/reperfusionNatascha C Nüssler, Andrea R Müller, Hans Weidenbach, et al.
Clinical Transplantation|July 11, 2006
Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantationJan M Langrehr, Jochen Klupp, Matthias Glanemann, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 22, 2006
Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation--a randomized clinical trialChristoph Heidenhain, Michael Heise, Sven Jonas, et al.
Head & Neck|December 19, 2014
Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantationAnnekatrin Coordes, Andreas E Albers, Minoo Lenarz, et al.
European Journal of Gastroenterology & Hepatology|May 1, 2013
Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspectiveMassimo Colombo, Jean-Luc Raoul, Riccardo Lencioni, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 13, 2008
Graft versus host disease after liver transplantation - a single center experience and review of literatureSven Kohler, Andreas Pascher, Guido Junge, et al.
Kidney International|May 30, 2008
Ischemic preconditioning produces systemic protective and adoptively transferable effectsAnja Reutzel-Selke, Johann Pratschke, Paulo N Martins, et al.
Pageof 44